|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o AEterna Zentaris Inc., of Quebec City, promoted Jurgen Ernst from vice chairman to chairman of the board of directors. Ernst replaces company founder Eric Dupont, who retired. Additionally, AEterna Zentaris President and CEO David Mazzo was appointed to the board.
o ArGentis Pharmaceuticals LLC, of Memphis, Tenn., licensed from the University of Tennessee Research Foundation intellectual property surrounding the use of solubilized Type I native bovine collagen as a treatment for systemic sclerosis and other fibrosing diseases. In a National Institutes of Health-funded, double-blind, placebo-controlled, 168-patient Phase II trial, the collagen treatment ...
Related newspaper, magazine, and journal articles:
|